Tourmaline Bio, Inc.
TRML
$19.10
$0.0950.50%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.31% | -10.20% | -15.38% | -31.37% | -3.17% |
| Total Depreciation and Amortization | 33.33% | -10.00% | 0.00% | 0.00% | -9.09% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 482.23% | 54.40% | 13.08% | -364.36% | -94.97% |
| Change in Net Operating Assets | -65.71% | 153.92% | -8,521.21% | 98.18% | -814.14% |
| Cash from Operations | -3.78% | 10.90% | -30.19% | -20.67% | -59.55% |
| Capital Expenditure | 0.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 58.24% | 240.22% | -15.44% | 94.64% | -4,947.77% |
| Cash from Investing | 58.27% | 240.15% | -15.44% | 94.64% | -4,950.26% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -133.33% | -200.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 18,833.33% | -200.00% | -- | -100.00% | 136.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 207.15% | 87.19% | -24.88% | 33.70% | -167.71% |